http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102532151-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-22 |
| filingDate | 2012-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102532151-B |
| titleOfInvention | There is 7-ethyl-20 (the S)-O-substituted benzoyl camptothecine compounds of anti-tumor activity |
| abstract | The invention discloses 7-ethyl-20 (the S)-O-substituted benzoyl camptothecine compounds that a class has anti-tumor activity, it has formula (3) structure, wherein, and Rn 1 hydrogen, nitro or trifluoromethyl; Rn 2 hydrogen, halogen, nitro, cyano group or trifluoromethyl; Rn 3 hydrogen or nitro; Compound of the present invention can be applicable to prepare anticancer medicine aspect. |
| priorityDate | 2012-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.